Deleted Tweets From Scott Gottlieb, R-D.C.

Do you have #Thanksgiving⁠ ⁠ leftovers to reheat? If so, be sure to follow these important #foodsafety rules to make sure that you & your family don’t get sick: https://t.co/2tzFVlmC4q #WhenInDoubtThrowItOut https://t.co/lY1gTbfsCl

UPDATE ON OUTBREAK: The romaine implicated in the current outbreak is likely from California based on growing and harvesting patterns. The goal now is to withdraw the product that’s at risk of being contaminated from the market, and then re-stock the market.....

....New romaine from different growing regions, including Florida and Arizona, will soon be harvested. We’re working with growers and distributors on labeling produce for location and harvest date and possibly other ways of informing consumers that the product is “post-purge”....

....We want to help unaffected growers get back into production and enable stores and consumers to re-stock. One goal we’re seeking is to make this type of labeling the new standard rather than a short-term fix; as a way to improve idenfitifaction and traceability in the system.

RT @SecAzar: The single best way to protect yourself and your loved ones from the flu is to get vaccinated. As flu season approa… https://t.co/ypmB06FyHA

2/2: #FDA wants providers and patients to be aware of problems like dosing errors, pump failure, opioid withdrawal, infection and others. We continue to monitor the safety of implantable pumps that treat and manage pain and will take action where needed. https://t.co/8mzrsDAdYY

@MartinSGaynor Thank you! Much appreciated.

#FDA formally establishes key new objective: That U.S. consistently be first among the world regulators to identify and act upon medical device safety signals. To achieve this target we're investing millions in a new post-market active surveillance system https://t.co/vB33GIpPLZ https://t.co/gT6iXH1vG6

RT @SGottliebFDA: #FDA formally establishes key new objective: That U.S. consistently be first among the world regulators to identify… https://t.co/prJWOSQc3t

RT @SGottliebFDA: Next week #FDA will unveil the most significant modernization of the 510(k) clearance pathway in a generation; alon… https://t.co/Vao7r95rc3

#FDA’s Center for Devices and Radiological Health is advancing an aggressive set of priorities in new guidance documents we aim to publish in FY2019. These reflect many diverse policy goals and how we plan to advance device safety and product innovation https://t.co/lJhKe4Gs1w https://t.co/69cB6PHif9

#FDA is modernizing how we regulate smartphone apps linked to prescription drugs — like medication reminders or symptom trackers — in a new proposal aimed at encouraging tools that help patients advance care and promote better interactions with providers. https://t.co/uVGA7CMyJ9

@daviesbj @MartinSGaynor Thanks Ben!

#FDA is currently receiving about 100 INDs a year for new gene therapy products and the pace of development is accelerating. The inflection point was the creation of reliable vectors. These technologies represent the the potential to cure vexing diseases. https://t.co/k5LnzfCuuD

#FDA is evaluating a population based standard for the approval of new opioid drugs. We’ll have a hearing soon to solicit public comment on its merits; if new opioids should need to demonstrate benefit over existing opioids to meet a standard for approval https://t.co/CJjwFwii6K

#FDA’s new drug shortage task force will evaluate payment policies, incentives to encourage manufacturing to ensure a stable drug supply, and the need for an essential drugs list and incentives for manufacturing critical drugs. All options are on the table https://t.co/1RIzoXApsU

RT @SGottliebFDA: Ensuring medical devices are safeguarded from cyber intrusions is a shared responsibility across the medical device… https://t.co/FR0cvgtTvy

RT @SGottliebFDA: FDA ALERT: Safety Communication - The #FDA Warns Against the use of Many Genetic Tests with Unapproved Claims to Pr… https://t.co/pQvKBo3YzR

#FDA issues warning letters to 2 companies for products labeled as dietary supplements that contain tianeptine; a compound being illegally mareketed for OUD, pain, anxiety, and other unproven claims. These actions follow reports of serious adverse events. https://t.co/kk7ScqiEfC

This year #FDA will receive 250 IND applications for novel cell and gene therapies; about 100 will be for gene therapies. By 2021 we expect the annual total to reach 1,000. These fields are exploding; and hold tremendous promise for advancing public health https://t.co/k5LnzfCuuD https://t.co/2dQFQKGFH2

Do you have #Thanksgiving⁠ ⁠ leftovers to reheat? If so, be sure to follow these important #foodsafety rules to make sure that you & your family don’t get sick: https://t.co/2tzFVlmC4q #WhenInDoubtThrowItOut https://t.co/lY1gTbfsCl

UPDATE ON OUTBREAK: The romaine implicated in the current outbreak is likely from California based on growing and harvesting patterns. The goal now is to withdraw the product that’s at risk of being contaminated from the market, and then re-stock the market.....

....New romaine from different growing regions, including Florida and Arizona, will soon be harvested. We’re working with growers and distributors on labeling produce for location and harvest date and possibly other ways of informing consumers that the product is “post-purge”....

....We want to help unaffected growers get back into production and enable stores and consumers to re-stock. One goal we’re seeking is to make this type of labeling the new standard rather than a short-term fix; as a way to improve idenfitifaction and traceability in the system.

RT @SecAzar: The single best way to protect yourself and your loved ones from the flu is to get vaccinated. As flu season approa… https://t.co/ypmB06FyHA

2/2: #FDA wants providers and patients to be aware of problems like dosing errors, pump failure, opioid withdrawal, infection and others. We continue to monitor the safety of implantable pumps that treat and manage pain and will take action where needed. https://t.co/8mzrsDAdYY

@MartinSGaynor Thank you! Much appreciated.

#FDA formally establishes key new objective: That U.S. consistently be first among the world regulators to identify and act upon medical device safety signals. To achieve this target we're investing millions in a new post-market active surveillance system https://t.co/vB33GIpPLZ https://t.co/gT6iXH1vG6

RT @SGottliebFDA: #FDA formally establishes key new objective: That U.S. consistently be first among the world regulators to identify… https://t.co/prJWOSQc3t

RT @SGottliebFDA: Next week #FDA will unveil the most significant modernization of the 510(k) clearance pathway in a generation; alon… https://t.co/Vao7r95rc3

#FDA’s Center for Devices and Radiological Health is advancing an aggressive set of priorities in new guidance documents we aim to publish in FY2019. These reflect many diverse policy goals and how we plan to advance device safety and product innovation https://t.co/lJhKe4Gs1w https://t.co/69cB6PHif9

#FDA is modernizing how we regulate smartphone apps linked to prescription drugs — like medication reminders or symptom trackers — in a new proposal aimed at encouraging tools that help patients advance care and promote better interactions with providers. https://t.co/uVGA7CMyJ9

@daviesbj @MartinSGaynor Thanks Ben!

#FDA is currently receiving about 100 INDs a year for new gene therapy products and the pace of development is accelerating. The inflection point was the creation of reliable vectors. These technologies represent the the potential to cure vexing diseases. https://t.co/k5LnzfCuuD

#FDA is evaluating a population based standard for the approval of new opioid drugs. We’ll have a hearing soon to solicit public comment on its merits; if new opioids should need to demonstrate benefit over existing opioids to meet a standard for approval https://t.co/CJjwFwii6K

#FDA’s new drug shortage task force will evaluate payment policies, incentives to encourage manufacturing to ensure a stable drug supply, and the need for an essential drugs list and incentives for manufacturing critical drugs. All options are on the table https://t.co/1RIzoXApsU

RT @SGottliebFDA: Ensuring medical devices are safeguarded from cyber intrusions is a shared responsibility across the medical device… https://t.co/FR0cvgtTvy

RT @SGottliebFDA: FDA ALERT: Safety Communication - The #FDA Warns Against the use of Many Genetic Tests with Unapproved Claims to Pr… https://t.co/pQvKBo3YzR

#FDA issues warning letters to 2 companies for products labeled as dietary supplements that contain tianeptine; a compound being illegally mareketed for OUD, pain, anxiety, and other unproven claims. These actions follow reports of serious adverse events. https://t.co/kk7ScqiEfC

This year #FDA will receive 250 IND applications for novel cell and gene therapies; about 100 will be for gene therapies. By 2021 we expect the annual total to reach 1,000. These fields are exploding; and hold tremendous promise for advancing public health https://t.co/k5LnzfCuuD https://t.co/2dQFQKGFH2